Treatment of Zollinger-Ellison Syndrome With Prevacid

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to study the safety and efficacy of high dose Prevacid in the long-term treatment of patients who secrete abnormally large amounts of gastric acid.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Charles Mel Wilcox, MD
• Collaborator: Takeda Pharmaceuticals North America, Inc.
• Treatments: Dexlansoprazole; Lansoprazole

Criteria

Inclusion Criteria:

• Diagnosed with Zollinger-Ellison syndrome

Exclusion Criteria:

• Pregnant or lactating females